Literature DB >> 20351484

Tarantula toxin ProTx-I differentiates between human T-type voltage-gated Ca2+ Channels Cav3.1 and Cav3.2.

Tsuyako Ohkubo1, Jun Yamazaki, Kenji Kitamura.   

Abstract

ProTx-I peptide, a venom toxin of the tarantula Thrixopelma pruriens, has been reported to interact with voltage-gated ion channels. ProTx-I reduced Ba(2+) currents through recombinant human T-type voltage-gated Ca(2+) channels, Ca(v)3.1 (hCa(v)3.1), with roughly 160-fold more potency than through hCa(v)3.2 channels. Chimeric channel proteins (hCa(v)3.1/S3S4 and hCa(v)3.2/S3S4) were produced by exchanging fourteen amino acids in the hCa(v)3.1 domain IV S3-S4 linker region and the corresponding region of hCa(v)3.2 between each other. The ProTx-I sensitivity was markedly reduced in the hCa(v)3.1/S3S4 chimera as compared to the original hCa(v)3.1 channel, while the hCa(v)3.2/S3S4 chimera exhibited greater ProTx-I sensitivity than the original hCa(v)3.2 channel. These results suggest that the domain IV S3-S4 linker in the hCa(v)3.1 channel may contain residues involved in the interaction of ProTx-I with T-type Ca(2+) channels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351484     DOI: 10.1254/jphs.09356fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  9 in total

1.  Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel Modulators.

Authors:  Yan-Ling Zhang; Sean P Moran; Andrew Allen; David Baez-Nieto; Qihong Xu; Lei A Wang; William E Martenis; Joshua R Sacher; Jennifer P Gale; Michel Weïwer; Florence F Wagner; Jen Q Pan
Journal:  ACS Pharmacol Transl Sci       Date:  2022-02-25

Review 2.  From foe to friend: using animal toxins to investigate ion channel function.

Authors:  Jeet Kalia; Mirela Milescu; Juan Salvatierra; Jordan Wagner; Julie K Klint; Glenn F King; Baldomero M Olivera; Frank Bosmans
Journal:  J Mol Biol       Date:  2014-08-01       Impact factor: 5.469

3.  A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.

Authors:  Junhong Gui; Boyi Liu; Guan Cao; Andrew M Lipchik; Minervo Perez; Zoltan Dekan; Mehdi Mobli; Norelle L Daly; Paul F Alewood; Laurie L Parker; Glenn F King; Yufeng Zhou; Sven-Eric Jordt; Michael N Nitabach
Journal:  Curr Biol       Date:  2014-02-13       Impact factor: 10.834

4.  Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

Authors:  Seungkyu Lee
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

5.  Characterisation of d-Conotoxin TxVIA as a Mammalian T-Type Calcium Channel Modulator.

Authors:  Dan Wang; S W A Himaya; Jean Giacomotto; Md Mahadhi Hasan; Fernanda C Cardoso; Lotten Ragnarsson; Richard J Lewis
Journal:  Mar Drugs       Date:  2020-06-30       Impact factor: 5.118

Review 6.  Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy.

Authors:  Saumya Bajaj; Jingyao Han
Journal:  Front Pharmacol       Date:  2019-02-26       Impact factor: 5.810

Review 7.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

8.  Block of T-type calcium channels by protoxins I and II.

Authors:  Chris Bladen; Jawed Hamid; Ivana A Souza; Gerald W Zamponi
Journal:  Mol Brain       Date:  2014-05-09       Impact factor: 4.041

9.  Bordetella Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses CaV3.1 as the Cell Surface Receptor.

Authors:  Shihono Teruya; Yukihiro Hiramatsu; Keiji Nakamura; Aya Fukui-Miyazaki; Kentaro Tsukamoto; Noriko Shinoda; Daisuke Motooka; Shota Nakamura; Keisuke Ishigaki; Naoaki Shinzawa; Takashi Nishida; Fuminori Sugihara; Yusuke Maeda; Yasuhiko Horiguchi
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.